These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4130889)

  • 1. [Hyperplasia of prolactin cells after estrogen therapy in carcinoma of the prostate (author's transl)].
    Hachmeister U
    Verh Dtsch Ges Pathol; 1972; 56():535-9. PubMed ID: 4130889
    [No Abstract]   [Full Text] [Related]  

  • 2. Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia.
    Suarez C; Díaz-Torga G; González-Iglesias A; Cristina C; Becu-Villalobos D
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E786-94. PubMed ID: 14722030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Irradiation for prevention of gynecomastia prior to estrogen therapy in cases of carcinoma of the prostate (author's transl)].
    Rost A; Rühl U; Brosig W
    Urologe A; 1977 Mar; 16(2):83-7. PubMed ID: 404747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intra- and extracellular electrolyte concentration of estrogen therapy on patients with carcinoma of the prostate (author's transl)].
    Kunze U; Orestano F
    Urologe A; 1973 Sep; 12(5):274-7. PubMed ID: 4762689
    [No Abstract]   [Full Text] [Related]  

  • 5. [Carcinoma of the breast under estrogen-treatment for prostatic carcinoma (author's transl)].
    Bülow H; Wullstein HK; Böttger G; Schröder FH
    Urologe A; 1973 Sep; 12(5):249-53. PubMed ID: 4357698
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cancer of the prostate: estrogen therapy].
    Mauriac L; Richaud P; Mage P; Thomas L; Lamarche P
    Bull Cancer; 1986; 73(1):23-30. PubMed ID: 3779120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular complications of oestrogen treatment in prostatic carcinoma (author's transl)].
    Héritier P; Hessler D
    Ther Umsch; 1978 Oct; 35(10):841-4. PubMed ID: 705679
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in hormonal homeostasis and development of disorders of the cardiovascular system in patients with prostatic cancer on estrogen therapy].
    Gembitskiĭ EV; Begunov AV
    Klin Med (Mosk); 1991 Dec; 69(12):59-63. PubMed ID: 1724022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of histological and cytological studies of the prostate with special reference to oestrogene induced changes (author's transl)].
    Schubert GE; Ziegler H; Völter D
    Verh Dtsch Ges Pathol; 1973; 57():315-8. PubMed ID: 4142204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current possibilities in the treatment of carcinoma of the prostate gland (author's transl)].
    Tomasović D; Grims P; Bencić K
    Lijec Vjesn; 1976 Apr; 98(4):185-8. PubMed ID: 61554
    [No Abstract]   [Full Text] [Related]  

  • 11. Some aspects of the pathogenesis of prostatic hyperplasia.
    Tveter KJ
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():167-74. PubMed ID: 4141576
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cancer of the breast in patients having prostatic cancer treated with estrogens. Report of three cases (author's transl)].
    Dore B; Dombriz M; Denis P; Darracq-Paries JC; Barbier J; Aubert J
    J Urol (Paris); 1982; 88(4):247-52. PubMed ID: 7108255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orchidectomy and oestrogen therapy of carcinoma of the prostate (author's transl)].
    Straube W; Braun JS
    Urologe A; 1974 Jul; 13(4 Pt A):198-201. PubMed ID: 4137442
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prolactin and cancer of the prostate (III). Changes in plasma prolactin and testosterone after hormone treatment in prostatic cancer].
    Maganto Pavón E; Mateos Torres JA; Mayayo Dehesa T; Allona Almagro A; Boronat Tormo F; Escudero Barrilero A
    Arch Esp Urol; 1982; 35(4):222-33. PubMed ID: 7138091
    [No Abstract]   [Full Text] [Related]  

  • 15. Sex hormones--effects on prolactin cells.
    el Etreby MF; Günzel P
    Acta Endocrinol Suppl (Copenh); 1974; 189():1-15. PubMed ID: 4135104
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of estrogen-resistant forms of cancer of the prostate].
    Marinbakh EB; Ar'e VM
    Urol Nefrol (Mosk); 1974; 39(4):68-74. PubMed ID: 4606039
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary-energy but not protein consumption.
    Shull JD; Birt DF; McComb RD; Spady TJ; Pennington KL; Shaw-Bruha CM
    Mol Carcinog; 1998 Oct; 23(2):96-105. PubMed ID: 9808163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone therapy of prostatic cancer (author's transl)].
    Altwein JE; Jacobi GH
    Urologe A; 1980 Nov; 19(6):350-7. PubMed ID: 7193368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Irradiation of the breast glands as prophylactic treatment of an estrogen-induced gynecomastia in patients with prostate carcinomas (author's transl)].
    Metzger H; Junker A; Voss AC
    Strahlentherapie; 1980 Feb; 156(2):102-4. PubMed ID: 7355408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.